title: Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine.
abstract: Domestic ducks are key intermediates in the transmission of H5N1 highly pathogenic avian influenza (HPAI) viruses, and therefore are included in vaccination programs to control H5N1 HPAI. Although vaccination has proven effective in protecting ducks against disease, different species of domestic ducks appear to respond differently to vaccination, and shedding of the virus may still occur in clinically healthy vaccinated populations. In this study we compared the response to vaccination between two common domestic duck species, Pekin (Anas platyrhynchos domesticus) and Muscovy (Cairina moschata), which were vaccinated with a commercial inactivated vaccine using one of three different schedules in order to elicit protection to H5N1 HPAI before one month of age. Clear differences in responses to vaccination were observed; the Muscovy ducks developed lower viral antibody titers induced by the same vaccination as Pekin ducks and presented with higher morbidity and mortality after challenge with an H5N1 HPAI virus. When comparing the response to infection in non-vaccinated ducks, differences were also observed, with infected Muscovy ducks presenting a lower mean death time and more severe neurological signs than Pekin ducks. However Pekin ducks had significantly higher body temperatures and higher levels of nitric oxide in the blood at 2 days post challenge than Muscovy ducks, indicating possible differences in innate immune responses. Comparison of the expression of innate immune related genes in spleens of the non-vaccinated infected ducks showed differences including significantly higher levels of expression of RIG-I in Pekin ducks and of IL-6 in Muscovy ducks. Both duck species showed an up-regulation of IFNα and MHC-I expression, and a down-regulation of MHC-II. In conclusion, differences in response to infection and vaccination were observed between the two domestic duck species. This information should be taken into account when developing effective vaccination programs for controlling H5N1 HPAI in different species of ducks.
authors.affiliation: Southeast Poultry Research Laboratory, Exotic and Emerging Avian Viral Diseases Unit, Agricultural Research Service, US Department of Agriculture, 934 College Station Road, Athens, GA 30605, USA.
authors.forename: Caran
authors.initials: C
authors.lastname: Cagle
authors.forename: Thanh Long
authors.initials: TL
authors.lastname: To
authors.forename: Tung
authors.initials: T
authors.lastname: Nguyen
authors.forename: Jamie
authors.initials: J
authors.lastname: Wasilenko
authors.forename: Sean C
authors.initials: SC
authors.lastname: Adams
authors.forename: Carol J
authors.initials: CJ
authors.lastname: Cardona
authors.forename: Erica
authors.initials: E
authors.lastname: Spackman
authors.forename: David L
authors.initials: DL
authors.lastname: Suarez
authors.forename: Mary J
authors.initials: MJ
authors.lastname: Pantin-Jackwood
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001831:Body Temperature; D004372:Ducks; D020869:Gene Expression Profiling; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D005585:Influenza in Birds / Q000276:immunology* / Q000401:mortality / Q000473:pathology / Q000517:prevention & control*; D007963:Leukocytes, Mononuclear / Q000276:immunology; D009569:Nitric Oxide / Q000097:blood; D013154:Spleen / Q000276:immunology; D016019:Survival Analysis; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D009569:Nitric Oxide